The Impact of use of Energy Devices during Parenchymal Transection of the Liver: a multicenter randomized controlled trial
Not Applicable
Completed
- Conditions
- iver tumor
- Registration Number
- JPRN-UMIN000006044
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Not provided
Exclusion Criteria
1)the size of tumor is less than 20mm in diameter and tumor is solitary, and located in the surface of the liver. 2)Patinets will undergo hepatectomy and other surgical procedures (excluded cholecystectomy) 3)Patients cannot understand this study. 4)Pregnancy patients 5)Doctors considered that patient was not eligible.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of cases to the blood loss over 1000ml between the 2 groups
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie energy device use in liver tumor resection for improved outcomes?
How do energy devices compare to standard surgical techniques in liver tumor parenchymal transection?
What biomarkers predict optimal response to energy device-assisted liver tumor surgery?
What are the potential adverse events associated with energy device use during liver parenchymal transection?
What combination approaches or alternative technologies are being explored for liver tumor resection alongside energy devices?